In agreement with the proteomic results, functional assays reported an up-regulation of the vascular cell adhesion molecule (VCAM1), a marker of endothelial dysfunction and inflammation correlated with CVD 33, in response to all positive COVID-19 serums, whether from asymptomatics or critical patients (Figure 6D). Here, VCAM1 is linked to endothelial dysfunction.